Covaxin Phase 2, 3 Clinical Trials For 2-18 Age Group Cleared

0

Covaxin maker Bharat Biotech has said the trial will be carried out on “525 healthy volunteers”.

Covaxin Phase 2, 3 Clinical Trials For 2-18 Age Group Cleared

The Covaxin trial involves two vaccine doses injected at day 0 and day 28.



New Delhi:

Clinical trials of Covaxin for children from two and 18 years has been cleared by the Drugs Controller General of India (DCGI).

Covaxin maker Bharat Biotech has said the trial will be carried out on “525 healthy volunteers”.

According to a government statement, the drug regulator accepted the recommendation of an expert committee on vaccines.

The trial involves two vaccine doses injected at day 0 and day 28.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

All the data shown above will be stored by www.rajpostexam.com on https://www.rajpostexam.com/. At any point of time, you can contact us and select the data you wish to anonymise or delete so it cannot be linked to your email address any longer. When your data is anonymised or deleted, you will receive an email confirmation. We also use cookies and/or similar technologies to analyse customer behaviour, administer the website, track users' movements, and to collect information about users. This is done in order to personalise and enhance your experience with us. Click here to read our Cookie Policy.